2016
DOI: 10.1016/j.jprot.2016.06.030
|View full text |Cite
|
Sign up to set email alerts
|

Biotypes analysis of Corynebacterium glutamicum growing in dicarboxylic acids demonstrates the existence of industrially-relevant intra-species variations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 72 publications
0
1
0
Order By: Relevance
“…The yield improvement of microbial products has been traditionally faced up by means of: (i) treatment with mutagenic agents (e.g., nitrogen mustards, ultraviolet irradiation, X-ray); (ii) increasing the biosynthetic genes; or (iii) redirecting the metabolic precursors [ 73 ]. As a consequence, a promising strategy is metabolic engineering (see Table 1 ), which includes: (i) the overexpression of carotenoid biosynthetic genes (e.g., crtYB gene); (ii) the metabolic flow increase towards the synthesis of specific pathway precursor molecules (e.g., geranylgeranyl-pyrophosphate synthase encoding gene ( crtE )), or (iii) the supplementation with carotenogenesis precursors (e.g., mevalonate) [ 20 , 47 , 62 , 74 , 75 ].…”
Section: Biotechnology-based Improvement Of Astaxanthin Productionmentioning
confidence: 99%
“…The yield improvement of microbial products has been traditionally faced up by means of: (i) treatment with mutagenic agents (e.g., nitrogen mustards, ultraviolet irradiation, X-ray); (ii) increasing the biosynthetic genes; or (iii) redirecting the metabolic precursors [ 73 ]. As a consequence, a promising strategy is metabolic engineering (see Table 1 ), which includes: (i) the overexpression of carotenoid biosynthetic genes (e.g., crtYB gene); (ii) the metabolic flow increase towards the synthesis of specific pathway precursor molecules (e.g., geranylgeranyl-pyrophosphate synthase encoding gene ( crtE )), or (iii) the supplementation with carotenogenesis precursors (e.g., mevalonate) [ 20 , 47 , 62 , 74 , 75 ].…”
Section: Biotechnology-based Improvement Of Astaxanthin Productionmentioning
confidence: 99%